Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
International Journal of Clinical Pharmacy
Metadata
Title
Factors influencing the length of hospitalisation in intensive care units: a prospective observational study
Authors
Franca Vacca
Monica Vaiani
Andrea Messori
Sabrina Trippoli
Susanna Maltoni
Filippo Pelagotti
Benedetta Santarlasci
Filippo Bardelli
Publication date
01-10-2004
Publisher
Kluwer Academic Publishers
Published in
International Journal of Clinical Pharmacy / Issue 5/2004
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1023/B:PHAR.0000042880.12835.4e

Other articles of this Issue 5/2004

International Journal of Clinical Pharmacy 5/2004 Go to the issue

OriginalPaper

Development of a community pharmacy-based model to identify and treat OTC drug abuse/misuse: a pilot study

OriginalPaper

Computer-assisted medication review for asthmatic patients as a basis for intervention Constructing and validating an algorithmic computer instrument in pharmacy practice

OriginalPaper

Evidence-based design

OriginalPaper

Decrease of antiparkinsonian drugs before start of an antipsychotic in patients on levodopa treatment?

Commentary

Randomised controlled trials (RCTs) to evaluate complex healthcare interventions - a case study

OriginalPaper

Pharmacogenetics in health-care practice

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits